Sera Prognostics, Inc. - Class A Common Stock (SERA)
3.9000
-0.0300 (-0.76%)
Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions
The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants.
Frequently Asked Questions
Is Sera Prognostics, Inc. - Class A Common Stock publicly traded?
Yes, Sera Prognostics, Inc. - Class A Common Stock is publicly traded.
What exchange does Sera Prognostics, Inc. - Class A Common Stock trade on?
Sera Prognostics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sera Prognostics, Inc. - Class A Common Stock?
The ticker symbol for Sera Prognostics, Inc. - Class A Common Stock is SERA on the Nasdaq Stock Market
What is the current price of Sera Prognostics, Inc. - Class A Common Stock?
The current price of Sera Prognostics, Inc. - Class A Common Stock is 3.900
When was Sera Prognostics, Inc. - Class A Common Stock last traded?
The last trade of Sera Prognostics, Inc. - Class A Common Stock was at 4:00 pm EDT on March 27th, 2025